Clinical Trials Logo

Clinical Trial Summary

The study was a single center observational-prospective study and approved by local ethics committee. Patients in coma state due to traumatic brain injury, cardiac arrest or ischemic stroke who are older than 18 years of age were included in the study. Patients who received amantadine 200mg/day for fourteen days according to ICU protocols decided by primary physician formed the amantadine group, and the rest of the subjects were included in the control group. All patients were evaluated for Glasgow Coma Score, JFK Coma Recovery Scale and Disability Rating Scale once a week for three months.


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms


NCT number NCT03443037
Study type Observational
Source Dokuz Eylul University
Contact Kutlay Aydin, MD
Phone +905322649294
Email kutlayaydin@hotmail.com
Status Recruiting
Phase
Start date March 1, 2016
Completion date July 1, 2019

See also
  Status Clinical Trial Phase
Active, not recruiting NCT06443827 - Effect of Intravenous Amantadine Sulphate on Disorders of Consciousness Phase 2
Recruiting NCT04367883 - Influenza Vaccination, ACEI and ARB in the Evolution of SARS-CoV2 Infection